We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Automated Workstation Screens Urine Before Culture

By LabMedica International staff writers
Posted on 20 Feb 2013
Automated systems have been developed to screen urine in order to eliminate those in which a culture is highly unlikely to yield clinically relevant results.

A flow cytometry system that quantifies urine elements associated with urinary tract infection (UTI) has recently added a new element, the detection of “all small particles” (ASP) to improve the sensitivity of the assay.

Scientists at the Veterans Affairs Medical Center (Houston, TX, USA) evaluated 1,000 urine specimens submitted consecutively that had a urine culture and urinalysis ordered on the same day. More...
Specimens were tested for leukocyte esterase and nitrite with a chemistry dipstick analyzer and for white blood cells (WBC), ASP, bacteria, and yeast with an automated urinalysis system. Urinary samples were also tested on bacterial culture plates.

There were 893 samples from male patients, and 107 from females. There were 123 specimens from patients with indwelling urinary catheters. Of the 1,000 specimens evaluated 604 (60.4%) were culture positive at any level, that is equal to or greater than 103 colony forming units (CFU)/mL. Two combinations of results available on the iQ200 Workstation (Iris Diagnostics; Chatsworth, CA, USA) were assessed for sensitivity, specificity, and negative predictive value (NPV).One method assessed leukocyte esterase, WBCs, nitrite, and the presence of few or more bacteria or yeast, a combination chosen to reflect the current parameters combination of manual urinalysis strips and standard microscopy. The other method assessed WBCs, the presence of few or more bacteria or yeast, and an ASP count of greater than 10,000, thus eliminating the redundancy of biochemical markers and focusing on the microscopic elements available on the iQ200.

The iQ200 Workstation is used in combination with the Aution Max AX-4280 chemistry dipstick analyzer (Arkray; Edina, MN, USA). The scientists found that the dipstick analysis added no advantage in a laboratory with microscopy. Although specificities were generally low, between 65.6% and 70.1%, the goal for screening samples is high sensitivity and NPV. The NPV approached 95% in comparison to the gold standard, but was further improved to greater than 99% when compared to the ordering clinician's diagnosis or an expert review that assessed the indications in the record that a UTI was present. The authors concluded that ASP did not enhance specificity, sensitivity, or NPV. The iQ200 Workstation performed well by any standard, thus providing a reliable system by which to improve the use of laboratory resources. The study was published in the January 2013 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Veterans Affairs Medical Center
Iris Diagnostics
Arkray



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.